Royalty Pharma plc (RPRX)

Royalty Pharma Revenue

Royalty Pharma had revenue of $564.69M in the quarter ending September 30, 2024, with 5.29% growth. This brings the company's revenue in the last twelve months to $2.27B, down -2.51% year-over-year. In the year 2023, Royalty Pharma had annual revenue of $2.35B with 5.24% growth.

• Revenue (ttm): $2.27B
• Revenue Growth: -2.51%
• P/S Ratio: 6.32
• Revenue / Employee: $25,460,708
• Employees: 89
• Market Cap: 18.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.35B	117.34M	5.24%
Dec 31, 2022	2.24B	-52.25M	-2.28%
Dec 31, 2021	2.29B	167.11M	7.87%
Dec 31, 2020	2.12B	308.10M	16.98%
Dec 31, 2019	1.81B	19.36M	1.08%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.